Dolby Laboratories (DLB) Liabilities and Shareholders Equity (2009 - 2026)

Dolby Laboratories (DLB) has 18 years of Liabilities and Shareholders Equity data on file, last reported at $3.2 billion in Q2 2026.

• Quarterly Liabilities and Shareholders Equity fell 1.23% year-over-year to $3.2 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $12.8 billion (up 1.04% YoY) and the FY2025 annual result came in at $3.2 billion, up 3.79% from the prior year.
• Liabilities and Shareholders Equity slipped to $3.2 billion in Q2 2026, from $3.2 billion in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $3.2 billion in Q1 2026 to a low of $2.7 billion in Q3 2022.
• A 5-year average of $3.0 billion and a median of $3.1 billion in 2022 frame the typical range for Liabilities and Shareholders Equity.
• Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity decreased 13.4% — and 2023, when it climbed 10.79%.
• Tracing DLB's Liabilities and Shareholders Equity over 5 years: stood at $2.7 billion in 2022, then grew by 6.8% to $2.9 billion in 2023, then advanced by 7.6% to $3.2 billion in 2024, then increased by 1.06% to $3.2 billion in 2025, then dropped by 1.11% to $3.2 billion in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $3.2 billion (Q2 2026), $3.2 billion (Q1 2026), and $3.2 billion (Q4 2025), per Business Quant data.